focus -WSS

focus

author：entertainment 2025-09-28 15:57:09 - browse：24163

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Health AI: on the border between health care and tech

WSS

Why Eli Lilly’s earnings didn’t quite live up to the hype

Congress considering partial increase for doctor pay in Medicare

What to know about the judge who will handle the Trump case

Timeline: How the deadly wildfires took over Maui day by day

Abbott's new heart device gets FDA advisory panel nod

Resistance to opioid

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Mark Cuban is blaming the wrong people for high drug costs

Bright Health sells Medicare Advantage business to Molina

Latigo launches with $135 million for Vertex

Novavax promises a turnaround & Lilly roils the obesity market

Maui wildfire now ranks as the fifth

Alkermes shareholders re

Surge in Apellis stock fueled by confidence in safety of its eye drug

What does generative AI mean for health care? We asked experts

Eli Lilly reports tirzepatide MASH success during Q4 earnings

focus

Montana youths win climate lawsuit against state for promoting fossil fuels

Congress might make insulin pumps more accessible to the blind

Bird flu researchers hone in on Finland’s mink farms

Biden administration begins canceling student loan debt for 804,000 borrowers

Dozens dead from Maui wildfires: What we know about the victims

Too many hospitalized Covid

leisure time

focus

knowledge

focus